Neurology Specific Literature Search   
 
[home][thesaurus]
    
Click Here to return To Results

 

Treatment of Autoimmune Myasthenia Gravis
Neurol 61:1652-1661, Richman,D.P. & Agius,M.A., 2003
See this aricle in Pubmed

Article Abstract
Remission induction is usually accomplished through the use of high-dose corticosteroids, frequently in conjunction with IV immunoglobulin or plasmapheresis. Maintenance of the remission is usually accomplished by slow tapering of the corticosteroids along with the use of ôsteroid-sparingö agents, which include azathioprine, thymectomy, and possibly mycophenolate. Therapy usually begins with cholinesterase inhibitors. If necessary, immune-directed treatment is added, beginning with eitherthymectomy or high-dose corticosteroids. The short-term therapies, i.e., IV immunoglobulin or plasmapheresis, may be effective in the early stages of treatment or later during an exacerbation. Steroid-sparing medications are usually added to facilitate the tapering phase.
 
Related Tags
(click to filter results - removes previous filter)

adverse drug reaction
anticholinesterase
autoimmune disease
azathioprine
cyclophosphamide
gammaglobulin therapy,intravenous
immunosuppressive agents
myasthenia gravis
myasthenia gravis,treatment of
mycophenolate
plasmapheresis
review article
steroid
steroid therapy,CNS treatment and complications with
treatment of neurologic disorder

Click Here to return To Results